Additionally, USP22 downregulates transferrin receptor (TFRC) transcription by removing H2B lysine 120 ubiquitination (H2BK120ub) from TFRC transcription start site (TSS) downstream region, thereby inhibiting Sorafenib‐induced ferroptosis in hepatocellular carcinoma. Here, TFRC is linked to hepatocellular carcinoma.